View More Recent Stories
-
BioVie Inc. (BIVI) Announces Proposed Share and Warrant Offering
-
BioVie Inc. (BIVI) Secures All Scientific Approvals Needed to Receive Additional $12.6M of Grant Funding
-
BioVie Inc. (BIVI) Announces FDA Authorization of IND for Phase 2 Trial to Evaluate Bezisterim in Long COVID
-
BioVie Inc. (BIVI) Announces Clinical Data Showing Epigenetic Basis for How Bezisterim May Modulate Inflammation and the Biological Aging Process
-
BioVie (BIVI) Announces Alignment with FDA on Clinical Trial to Assess Bezisterim in Parkinson’s Disease
-
BioVie Inc. (BIVI) Announces 1:10 Reverse Share Split
-
BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
BioVie and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
BioVie and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
